54 753 (Letrozole 2.5 mg)
Pill with imprint 54 753 is White, Round and has been identified as Letrozole 2.5 mg. It is supplied by Roxane Laboratories, Inc.
Letrozole is used in the treatment of female infertility; breast cancer; breast cancer, adjuvant; breast cancer, metastatic and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 54 753
Letrozole
- Imprint:
- 54 753
- Strength:
- 2.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Roxane Laboratories, Inc
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
silicon dioxide colloidal
magnesium stearate
sodium starch glycolate type A potato
pregelatinized corn starch
Note: Inactive ingredients may vary.
More about letrozole
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 116 Reviews – Add your own review/rating
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
